FDA Inspection 1084864 — Mercy Hospital Springfield - Transfusion Services

Mercy Hospital Springfield - Transfusion Services — FEI 1970683

The FDA completed an inspection of Mercy Hospital Springfield - Transfusion Services on March 19, 2019 in Springfield, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 19, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Springfield, MO (United States)